Inicio>>Lipids>> Fatty Amides>>Arachidonoyl Cyclopropylamide

Arachidonoyl Cyclopropylamide (Synonyms: ACPA)

Catalog No.GC18615

Arachidonoyl ciclopropilamida (ACPA) es un agonista potente y selectivo del receptor cannabinoide (CB) 1 con valores de Ki de 2,2 y 715 nM para los receptores CB1 y CB2, respectivamente.

Products are for research use only. Not for human use. We do not sell to patients.

Arachidonoyl Cyclopropylamide Chemical Structure

Cas No.: 229021-64-1

Tamaño Precio Disponibilidad Cantidad
5mg
48,00 $
Disponible
10mg
92,00 $
Disponible
50mg
385,00 $
Disponible
100mg
673,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Arachidonoyl cyclopropylamide (ACPA) is a potent and selective cannabinoid (CB) receptor 1 agonist with Ki values of 2.2 and 715 nM for CB1 and CB2 receptors, respectively. In whole animal experiments, ACPA induces hypothermia in mice with the same efficacy as arachidonoyl ethanolamide , in spite of its higher affinity for the CB1 receptor. These data have been interpreted to indicate that ACEA may be a substrate for fatty acid amide hydrolase (FAAH), and thus only transiently available in whole animal experiments.

References:
[1].Pertwee, R.G. Pharmacology of cannabinoid receptor ligands Curr. Med. Chem. 6(8), 635-664 (1999).
[2]. Hillard, C.J., Manna, S., Greenberg, M.J., et al. Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1) J. Pharmacol. Exp. Ther. 289(3), 1427-1433 (1999).

Reseñas

Review for Arachidonoyl Cyclopropylamide

Average Rating: 5 ★★★★★ (Based on Reviews and 9 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Arachidonoyl Cyclopropylamide

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.